Video Transcript
Tommy Sternberg
CFA, Partner, Research Analyst, Global Equity Team
Richard Reznick
Ph.D., Research Analyst, Global Equity Team
Hi everyone. We’re here in Switzerland, in front of Lake Zurich, just outside of Zurich, Switzerland. We just wrapped up a week of meetings all over the country, and it was a really fantastic set of meetings. Rich, for you, what were some of the key topics or themes that came up throughout? There’s a lot going on in the healthcare industry.
I’d say even though the pandemic is over, we still had a number of companies that were talking about dealing with COVID in their businesses. The other thing that really stood out was what’s happening with these GLP-1 weight loss drugs. A lot of impact across the industry and a number of companies talking about how that’s affecting them.
We’re obviously super focused on GLP-1. It’s a huge market trend. Interesting to see companies involved in the supply chain and how they’re all working together.
Disclosure
The views and opinions expressed herein are those of the speaker(s) as of the date of publication, are subject to change without notice as economic and market conditions dictate, and may not reflect the views and opinions of other investment teams within William Blair. Factual information has been obtained from sources we believe to be reliable, but its accuracy, completeness, or interpretation cannot be guaranteed. This material may include estimates, outlooks, projections, and other forward-looking statements. Due to a variety of factors, actual events may differ significantly from those presented. This video has been provided for informational purposes only and should not be considered as investment advice or a recommendation of any particular strategy or investment product, or as an offer to buy or sell any securities or related financial instruments in any jurisdiction. Investment advice and recommendations can be provided only after careful consideration of an investor’s objectives, guidelines, and restrictions. Investing involves risks, including the possible loss of principal. Past performance is not indicative of future results.